Press releases
Read more:
Categories
2026
The shareholders of Nanologica AB (publ), org.nr 556664-5023 (the "Company") are hereby invited to attend the Extraordinary General Meeting to...
2026-10-23 08:06
NANOLOGICA RESOLVES ON A PARTIALLY GUARANTEED RIGHTS ISSUE OF UNITS OF APPX. SEK 110.5 MILLION WITH AN OVERSUBSCRIPTION OPTION OF AN ADDITIONAL SEK 10 MILLION
Regulatory
MAR
The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") has today, based on the authorization granted by the...
2026-10-23 07:37
NANOLOGICA UPDATES STRATEGY AND APPOINTS NEW CEO TO DRIVE COMMERCIAL GROWTH AND PROFITABILITY
Regulatory
MAR
Nanologica AB has updated its strategy focusing on accelerating commercial growth, broadening the offering, and increasing focus on North America and Europe...
FINANCIAL SUMMARY SIGNIFICANT EVENTS DURING THE SECOND QUARTER SIGNIFICANT EVENTS AFTER THE END OF THE PERIOD CONTINUED STRENGTHENED COMMERCIAL POSITIONThe...
Nanologica's interim report for Q2 2026 will be published on Monday 31 August, instead of 20 August as previously announced. As a result of the acquisition...
Nanologica AB (publ) has appointed Axel Elner as new CFO. Axel Elner will take up the position on 10 November 2026. Axel Elner joins Nanologica from Viaplay...
2026-06-01 10:55
NANOLOGICA'S CFO LEAVES THE COMPANY
Nanologica's Chief Financial Officer Eva Osterman has decided to leave the company. Eva will remain in the Group until 31 August 2026 to ensure a...
Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the...
FINANCIAL SUMMARY SIGNIFICANT EVENTS DURING THE FIRST QUARTER SIGNIFICANT EVENTS AFTER THE END OF THE PERIOD INCREASED OPERATIONAL CAPACITY AND STRENGTHENED...
The number of registered shares and votes in Nanologica AB has changed during the month of April as a result of registration of issues resolved by the...